These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

167 related articles for article (PubMed ID: 32723273)

  • 1. Quetiapine Fumarate Loaded Nanostructured Lipid Carrier for Enhancing Oral Bioavailability: Design, Development and Pharmacokinetic Assessment.
    Agarwal S; HariKumar SL; Negi P; Upadhyay N; Garg R
    Curr Drug Deliv; 2021; 18(2):184-198. PubMed ID: 32723273
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Solid Lipid Nanoparticles Approach for Lymphatic Targeting Through Intraduodenal Delivery of Quetiapine Fumarate.
    Yasir M; Gaur PK; Puri D; Shehkar P; Kumar SS
    Curr Drug Deliv; 2018; 15(6):818-828. PubMed ID: 28545354
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Development and optimization of sulforaphane-loaded nanostructured lipid carriers by the Box-Behnken design for improved oral efficacy against cancer: in vitro, ex vivo and in vivo assessments.
    Soni K; Rizwanullah M; Kohli K
    Artif Cells Nanomed Biotechnol; 2018; 46(sup1):15-31. PubMed ID: 29183147
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Quality by Design Approach for Development and Characterisation of Solid Lipid Nanoparticles of Quetiapine Fumarate.
    Agarwal S; Murthy RSR; Harikumar SL; Garg R
    Curr Comput Aided Drug Des; 2020; 16(1):73-91. PubMed ID: 31429691
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Optimization of Nanostructured Lipid Carriers of Fenofibrate Using a Box-Behnken Design for Oral Bioavailability Enhancement.
    Wang H; Hong W; Li X; Jin Q; Ye W; Feng Y; Huang B; Tai Z; Chen L; Li Z; Wang Y; Yang Y; Gao C; Gong W; Yang M
    Curr Drug Deliv; 2022; 19(7):773-787. PubMed ID: 33902411
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Chlorogenic acid stabilized nanostructured lipid carriers (NLC) of atorvastatin: formulation, design and in vivo evaluation.
    Khan S; Baboota S; Ali J; Narang RS; Narang JK
    Drug Dev Ind Pharm; 2016; 42(2):209-20. PubMed ID: 26016780
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Comparative study of nisoldipine-loaded nanostructured lipid carriers and solid lipid nanoparticles for oral delivery: preparation, characterization, permeation and pharmacokinetic evaluation.
    Dudhipala N; Janga KY; Gorre T
    Artif Cells Nanomed Biotechnol; 2018; 46(sup2):616-625. PubMed ID: 29688077
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Enhancement of S(+)-zaltoprofen oral bioavailability using nanostructured lipid carrier system.
    Pham TMA; Lee DH; Na YG; Jin M; Jung M; Kim HE; Yoo H; Won JH; Lee JY; Baek JS; Han SC; Lee HK; Cho CW
    Arch Pharm Res; 2022 Nov; 45(11):822-835. PubMed ID: 36307644
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Quality by design approach to understand the process of optimization of iloperidone nanostructured lipid carriers for oral bioavailability enhancement.
    Mandpe L; Pokharkar V
    Pharm Dev Technol; 2015 May; 20(3):320-9. PubMed ID: 24328553
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Mucoadhesive chitosan-poly (lactic-co-glycolic acid) nanoparticles for intranasal delivery of quetiapine - Development & characterization in physiologically relevant 3D tissue models.
    Gadhave DG; Quadros M; Ugale AR; Goyal M; Ayehunie S; Gupta V
    Int J Biol Macromol; 2024 May; 267(Pt 2):131491. PubMed ID: 38599435
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Design and evaluations of a nanostructured lipid carrier loaded with dopamine hydrochloride for intranasal bypass drug delivery in Parkinson's disease.
    Neha SL; Mishra AK; Rani L; Paroha S; Dewangan HK; Sahoo PK
    J Microencapsul; 2023 Dec; 40(8):599-612. PubMed ID: 37787159
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Application of Statistical Tooling Techniques for Designing of Carvedilol Nanolipid Transferosomes and its Dermatopharmacokinetic and Pharmacodynamic Studies.
    Selvaraj BR; Sridhar SK; Kesavan BR; Palagati S
    Pharm Nanotechnol; 2020; 8(6):452-470. PubMed ID: 32988361
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Pharmacokinetics and Biodistribution of Thymoquinone-loaded Nanostructured Lipid Carrier After Oral and Intravenous Administration into Rats.
    Zakarial Ansar FH; Latifah SY; Wan Kamal WHB; Khong KC; Ng Y; Foong JN; Gopalsamy B; Ng WK; How CW; Ong YS; Abdullah R; Aziz MY
    Int J Nanomedicine; 2020; 15():7703-7717. PubMed ID: 33116496
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Fabrication and Characterization of Timolol Maleate and Brinzolamide Loaded Nanostructured Lipid Carrier System for Ocular Drug Delivery.
    Shrivastava N; Khan S; Baboota S; Ali J
    Curr Drug Deliv; 2018; 15(6):829-839. PubMed ID: 29189155
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Preparation, characterization, and
    Saghafi Z; Mohammadi M; Mahboobian MM; Derakhshandeh K
    Drug Dev Ind Pharm; 2021 Mar; 47(3):509-520. PubMed ID: 33650445
    [TBL] [Abstract][Full Text] [Related]  

  • 16. QbD aided development of ibrutinib-loaded nanostructured lipid carriers aimed for lymphatic targeting: evaluation using chylomicron flow blocking approach.
    Rangaraj N; Pailla SR; Shah S; Prajapati S; Sampathi S
    Drug Deliv Transl Res; 2020 Oct; 10(5):1476-1494. PubMed ID: 32519202
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Improved pharmacokinetics and antihyperlipidemic efficacy of rosuvastatin-loaded nanostructured lipid carriers.
    Rizwanullah M; Amin S; Ahmad J
    J Drug Target; 2017 Jan; 25(1):58-74. PubMed ID: 27186665
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Development of ritonavir-loaded nanostructured lipid carriers employing quality by design (QbD) as a tool: characterizations, permeability, and bioavailability studies.
    Gurumukhi VC; Bari SB
    Drug Deliv Transl Res; 2022 Jul; 12(7):1753-1773. PubMed ID: 34671949
    [TBL] [Abstract][Full Text] [Related]  

  • 19. A Full Factorial Design to Optimize Aminexil Nano Lipid Formulation to Improve Skin Permeation and Efficacy Against Alopecia.
    Makky AMA; S El-Leithy E; Hussein DG; Khattab A
    AAPS PharmSciTech; 2023 Jan; 24(1):40. PubMed ID: 36653508
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Bio-shielding In Situ Forming Gels (BSIFG) Loaded With Lipospheres for Depot Injection of Quetiapine Fumarate: In Vitro and In Vivo Evaluation.
    Abo Elela MM; ElKasabgy NA; Basalious EB
    AAPS PharmSciTech; 2017 Nov; 18(8):2999-3010. PubMed ID: 28493003
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.